The different colorectal tumor risk related to GLP-1 receptor agonists and SGLT2 inhibitors use: a network meta-analysis of 68 randomized controlled trials.

GLP-1 受體促效劑與 SGLT2 抑制劑使用與大腸直腸腫瘤風險之差異：68 項隨機對照試驗的網絡統合分析